Publisher
Springer Science and Business Media LLC
Reference7 articles.
1. Jeyaraman, M., Muthu, S., Nischith, D. S., Jeyaraman, N., Nallakumarasamy, A., & Khanna, M. (2022). PRISMA-compliant meta-analysis of randomized controlled trials on osteoarthritis of knee managed with allogeneic vs autologous MSCs: Efficacy and safety analysis. Indian Journal of Orthopaedics, 56(12), 2042–2059. https://doi.org/10.1007/s43465-022-00751-z
2. Arthur Vithran, D. T., Xie, W., Opoku, M., Essien, A. E., He, M., & Li, Y. (2023). The efficacy of platelet-rich plasma injection therapy in the treatment of patients with achilles tendinopathy: A systematic review and meta-analysis. Journal of Clinical Medicine, 12(3), 995. https://doi.org/10.3390/jcm12030995
3. Cheung, E. C., Hodax, J. D., Hsu, W. K., Williams, S. K., Smith, H. E., Lansdown, D. A., et al. (2020). Platelet-rich plasma, bone morphogenetic protein, and stem cell therapies. Instructional Course Lectures, 69, 273–288.
4. Knoepfler, P. S. (2015). From bench to FDA to bedside: US regulatory trends for new stem cell therapies. Advanced Drug Delivery Reviews, 82–83, 192–196. https://doi.org/10.1016/j.addr.2014.12.001
5. Muthu, S., Jeyaraman, M., Kotner, M. B., Jeyaraman, N., Rajendran, R. L., Sharma, S., et al. (2022). Evolution of mesenchymal stem cell therapy as an advanced therapeutic medicinal product (ATMP)-an indian perspective. Bioengineering (Basel, Switzerland), 9(3), 111. https://doi.org/10.3390/bioengineering9030111